Thermodynamic stability of wild-type and mutant p53 core domainAlex N. Bullock, Alan R. Fersht|Proceedings of the National Academy of Sciences|1997Cited by 417
The Tumor Suppressor p53: From Structures to Drug DiscoveryAndreas C. Joerger, Alan R. Fersht|Cold Spring Harbor Perspectives in Biology|2010Cited by 354
Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stabilityPenka V. Nikolova, Alan R. Fersht|Proceedings of the National Academy of Sciences|1998Cited by 253
Kinetic Instability of p53 Core Domain MutantsAssaf Friedler, Alan R. Fersht|Journal of Biological Chemistry|2003Cited by 141
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cellsMatthias R. Bauer, Alan R. Fersht|Proceedings of the National Academy of Sciences|2016Cited by 119